Chase Science Balance Sheet Health
Financial Health criteria checks 6/6
Chase Science has a total shareholder equity of CN¥1.3B and total debt of CN¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CN¥1.4B and CN¥84.0M respectively. Chase Science's EBIT is CN¥48.4M making its interest coverage ratio -1.4. It has cash and short-term investments of CN¥143.9M.
Key information
0%
Debt to equity ratio
CN¥0
Debt
| Interest coverage ratio | -1.4x |
| Cash | CN¥143.93m |
| Equity | CN¥1.28b |
| Total liabilities | CN¥83.97m |
| Total assets | CN¥1.37b |
Recent financial health updates
No updates
Recent updates
Chase Science's (SZSE:300941) Shareholders Will Receive A Smaller Dividend Than Last Year
Jun 17
Investors Could Be Concerned With Chase Science's (SZSE:300941) Returns On Capital
Jun 08More Unpleasant Surprises Could Be In Store For Chase Science Co., Ltd's (SZSE:300941) Shares After Tumbling 25%
Apr 21What Chase Science Co., Ltd's (SZSE:300941) 26% Share Price Gain Is Not Telling You
Mar 04Returns On Capital Signal Tricky Times Ahead For Chase Science (SZSE:300941)
Feb 27Financial Position Analysis
Short Term Liabilities: 300941's short term assets (CN¥1.3B) exceed its short term liabilities (CN¥66.2M).
Long Term Liabilities: 300941's short term assets (CN¥1.3B) exceed its long term liabilities (CN¥17.8M).
Debt to Equity History and Analysis
Debt Level: 300941 is debt free.
Reducing Debt: 300941 has not had any debt for past 5 years.
Debt Coverage: 300941 has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: 300941 has no debt, therefore coverage of interest payments is not a concern.